Butros Selim R, Shenoy-Bhangle Anuradha, Mueller Peter R, Arellano Ronald S
Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., White 270, Boston, MA 02114, USA.
Department of Radiology, Division of Abdominal Imaging and Intervention, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St., White 270, Boston, MA 02114, USA.
Clin Imaging. 2014 Jul-Aug;38(4):490-494. doi: 10.1016/j.clinimag.2014.01.013. Epub 2014 Feb 7.
A retrospective analysis of patients who underwent radiofrequency ablation (RFA) of intrahepatic cholangiocarcinoma (IHCC) was performed. Seven patients with 9 tumors underwent RFA. The mean tumor size was 2.4 cm (range=1.3-3.3 cm). RFA achieved technique effectiveness and local tumor control in 89% (8/9 tumors) of the patients respectively, with a mean overall survival of 38.5 months (range=12-69 months). To conclude, RFA was effective in achieving local tumor control and may offer a therapeutic option for patients with recurrent or primary IHCC.
对接受肝内胆管癌（IHCC）射频消融（RFA）治疗的患者进行了回顾性分析。7例患者共9个肿瘤接受了RFA治疗。肿瘤平均大小为2.4厘米（范围为1.3 - 3.3厘米）。RFA分别在89%（8/9个肿瘤）的患者中实现了技术有效性和局部肿瘤控制，平均总生存期为38.5个月（范围为12 - 69个月）。总之，RFA在实现局部肿瘤控制方面是有效的，并且可能为复发性或原发性IHCC患者提供一种治疗选择。
